Another Onglyza case filed

  • Onglyza (Saxagliptin) Side Effects Lawsuit - Medical Record Review | Neural IT

A product liability lawsuit was filed against Bristol-Myers Squibb and AstraZeneca by a woman who suffered heart failure and other severe cardiovascular complications alleging to be side effects of the saxagliptin-based diabetes drugs, Onglyza and Kombiglyze XR. The complaint was filed in the U.S. District Court for the Northern District of Alabama early December. The lawsuits state that the defendants had knowledge that there was a significantly increased risk of adverse events associated with Saxagliptin, despite this they continued to manufacture, market, distribute, sell, and profit from the sales of Saxagliptin. A request for consolidating Onglyza lawsuits was made recently. The U.S. JPML is expected to consider oral arguments on the motion during an upcoming hearing in January 2018.

We are social:

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

‘Rewards & Recognition Program’ Celebrations
‘Rewards & Recognition Program’ Celebrations!
Hurricane Relief Fund
We donated to Hurricane Relief Fund and got a signed ball from Kareem Abdul-Jabbar, the greatest
AAJ Annual Convention 2017
Neural IT sponsored TRT meeting was one of the active participants of AAJ Annual Convention 2017.

Latest Tweets